NetworkNewsBreaks Archive - Page 2184 of 2233

MondayFeb 06, 2017 1:17 pm

NetworkNewsBreaks – Aytu Bioscience, Inc.’s (AYTU) MiOXSYS® Platform Addresses Diagnostic Challenges of Male Infertility

Oxidative stress is known to be a contributing factor to male infertility, though a significant amount of infertility cases remain unexplained. This is largely due to a lack of standardized tests to determine oxidative stress. A new clinical application called MiOXSYS®, however, is set to change that by assessing oxidative stress levels in semen as an aid in the diagnosis of male infertility. The platform is being developed by Aytu BioScience (OTCQX: AYTU), a leading pharmaceutical company focusing on the commercialization of innovative urology products. The company is currently pursuing regulatory approval for commercialization in the United States while boosting…

MondayFeb 06, 2017 1:15 pm

NetworkNewsBreaks – Newtek Business Services Corp. (NASDAQ: NEWT) Embraces E-Commerce as Growing Payment Trend

As a business development company, Newtek Business Services (NASDAQ: NEWT) is focused on providing financial and business services to the small- and medium-sized business market. Through its electronic payment processing, managed technology solutions, small business finance, and Capcos segments, Newtek has helped increase revenues, reduce expenses and minimize risks for over 100,000 business accounts. Newtek’s electronic payment and eCommerce solutions portfolio companies processed $4.7 million in sales for its eCommerce merchants on Black Friday 2016, a substantial 12.6% increase over Black Friday the year prior. To learn more, visit www.newtekone.com About Newtek Business Services Corp. Newtek Business Services Corp., Your…

MondayFeb 06, 2017 1:14 pm

NetworkNewsBreaks – Accuray, Inc. (NASDAQ: ARAY) Covered at Aegis Capital with ‘Buy’ Rating, $7 PT

Aegis Capital Corp. has initiated coverage of Accuray (NASDAQ: ARAY), issuing a 'Buy' rating and $7 price target on the company's stock. Accuray is a radiation oncology company with distinctive, innovative products specifically designed for image-guided radiosurgery and intensity-modulated radiation therapy - two rapidly growing market segments. The company’s most recent financial results, for the second fiscal quarter and six months ended December 31, 2016, show second-quarter gross orders of $78.5 million with net orders of $54.1 million totaling year-over-year growth of 17%, as well as an ending backlog increase of 16% year-over-year to $426.2 million. To learn more, visit…

MondayFeb 06, 2017 12:03 pm

NetworkNewsBreaks – Top 10 Mid-day Percentage Gainers on February 6, 2017

Here is a list of stocks shaking up the markets today, with particular focus on NASDAQ and OTC small caps. The top gainers based on percentage: ETST 29.63% – News: Announces new wholly owned subsidiary, Cannabis Therapeutics, Inc. HTCO 24.10% – News: Accumulates close to $12M in prospective sales for its "grow.droid" platform FNBC 15.13% – News: Appoints new CEO NWBO 12.47% – News: Provides an update on phase III trial of DCVax®-L SIRC 12.32% – News: Supports the non-profit organization GRID Alternatives JTPY 11.07% – News: Enters agreement with the Office of the Illinois State Treasurer to become the…

MondayFeb 06, 2017 12:02 pm

NetworkNewsBreaks – Recon Technology (NASDAQ: RCON) Receives Authorization to Bid on Future ABB (NYSE: ABB) Projects

Recon Technology (NASDAQ: RCON) this morning announced it has received an authorization letter from ABB (NYSE: ABB), enabling Recon to bid on several of the power and automation technology company’s upcoming projects. Recon said it would provide on-site project commissioning and maintenance services to ABB for any successful project bids. "We are pleased to receive authorization from ABB, giving Recon recognition from the global pioneer of automation technology. Over the years, we have been committed to the exploration and development of new business opportunities outside our traditional oilfield sector. We are confident that our experience within the energy industry, as…

MondayFeb 06, 2017 12:00 pm

NetworkNewsBreaks – Ocean Power Technologies, Inc. (NASDAQ: OPTT) Inks Development and Marketing Agreement with HAI Technologies; Shares Surge

Ocean Power Technologies (NASDAQ: OPTT) (“OPT”) and HAI Technologies Corp. this morning announced they will seek mutual opportunities through a joint applications development and marketing agreement, initially concentrating on offshore oil and gas subsea chemical injection systems. Under the agreement, HAI Technologies’ advanced chemical injection solutions will be combined with OPT’s PB3 PowerBuoy® to generate new methods for long distance and remote offshore field developments. Shares of OPT are up 14% following the news. “We are excited to join efforts with such an innovative company as HAI Technologies. Chemical injection systems require persistent and reliable power, and we believe OPT’s…

MondayFeb 06, 2017 11:20 am

NetworkNewsBreaks – FDA Grants Small Business Status to Cytori (NASDAQ: CYTX)

Cytori (NASDAQ: CYTX) has been granted Small Business status for fiscal year 2017 by the U.S. Food and Drug Administration Division of Industry and Consumer Education. The designation allows Cytori to receive substantial financial incentives, fee reductions, and fee waivers for selective FDA medical device regulatory filings. The company is also eligible for a substantial reduction in many medical device user fees and a one-time waiver of the user fee for its first premarket approval (PMA) application, potentially occurring later in 2017. “Cytori Cell Therapy benefits from being regulated as a device through the PMA process. The small business designation…

MondayFeb 06, 2017 11:15 am

NetworkNewsBreaks – Rosetta Genomics (NASDAQ: ROSG) Receives Two U.S. Patent Allowances for RosettaGx Reveal™ microRNAs

Rosetta Genomics (NASDAQ: ROSG) shares are nudging higher after the company said the U.S. Patents and Trademark Office has granted two patent allowances for divisional patents of the parent application titled “microRNAs and uses thereof.” The company said the patents are important markers for its RosettaGX Reveal™ thyroid cancer assay, as this strengthens its intellectual property portfolio and provides opportunities for monetization. “We are creating a strong intellectual property position in microRNAs and thyroid cancer diagnostics. Of note, there are approximately 500 peer-reviewed publications that confirm the effectiveness of microRNAs as biomarkers in the diagnosis of thyroid cancer which makes…

FridayFeb 03, 2017 3:46 pm

NetworkNewsBreaks – Top 10 Mid-day Percentage Gainers on February 3, 2017

Here is a list of stocks shaking up the markets today, with particular focus on NASDAQ and OTC small caps. The top gainers based on percentage: AMRS 14.15% – News: Provides highlights of operational and financial results SRAX 6.44% - Appoints private equity investor Derek Ferguson to board of directors and audit committee TGTX 6.52% – News: Law firm files a securities class action lawsuit RWLK 5.95% – News: Law firm announces the filing of a class action lawsuit FNMA 3.08% – News: Announces delisting date from Euro MTF market of the Luxembourg Stock Exchange EARS 2.56% – News: Expands…

FridayFeb 03, 2017 3:44 pm

NetworkNewsBreaks – Soligenix, Inc.’s (NASDAQ: SNGX) SGX301 Receives Promising Innovative Medicine Designation in the UK; Aegis Capital Increases PT to $7

Shares of Soligenix (NASDAQ: SNGX) continued to climb Friday following the company’s announcement yesterday that its SGX301 was granted Promising Innovative Medicine (PIM) designation in the United Kingdom by the Medicines and Healthcare Products Regulatory Agency for the treatment of cutaneous T-cell lymphoma. The PIM designation is the first step toward inclusion in the Early Access to Medicines Scheme (EAMS), which provides severely ill patients with life-threatening and seriously debilitating conditions early access to groundbreaking new medicines - before marketing authorization is approved. "This is now the second of our programs to receive this important designation, with the first being…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

NetworkNewsBreaks